Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior

Neurology

Volumn 81, Issue 22, 2013, Pages 1900-1906

  Pugh, Mary Jo V ^a,b,c   Hesdorffer, Dale ^d   Wang, Chen Pin ^a,b   Amuan, Megan E ^e,f   Tabares, Jeffrey V ^a   Finley, Erin P ^a   Cramer, Joyce A ^g,h   Kanner, Andres M ⁱ   Bryan, Craig J ^j  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Department of Medicine ^*  (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e Vagelos College of Physicians and Surgeons   (United States)

^f Center for Health Quality Outcomes and Economic Research   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Epilepsy Therapy Project   (United States)

ⁱ RUSH UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITY OF UTAH   (United States)

more..

Author keywords

9th revision; AED 5 antiepileptic drug; ClinicalModification; FDA 5 US Food and Drug Administration; FY 5 fiscal year; GEE 5 general estimating equations; ICD 9 CM5 International Classification of Diseases; OR 5 odds ratio; PTSD 5 posttraumatic stress disorder; SRB 5 suicide related behavior; VA 5 Veterans Health Administration.

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

AGED; ARTICLE; AUTOMUTILATION; CLINICAL PRACTICE; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; FEMALE; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; VERY ELDERLY; VETERAN;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; COHORT STUDIES; DATABASES, FACTUAL; EPILEPSY; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SUICIDE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 84891941630     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436614.51081.2e     Document Type: Article

References (30)

1. U.S. Food and Drug Administration: Center for Drug Evaluation and Research. Information for healthcare professionals: suicidality and antiepileptic drugs [online]. Available at: http://www.fda.gov/cder/drug/ InfoSheets/HCP/antiepilepticsHCP.htm. Accessed July 18, 2008.
2. Olesen JB, Hansen PR, Erdal J, et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 2010;19:518-524.
3. Patorno E, Bohn RL, Wahl PM, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 2010;303:1401-1409.
4. Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010;363:542-551.
5. Machado RA, Espinosa AG, Melendrez D, Gonzalez YR, Garcia VF, Rodriguez YQ. Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. Seizure 2011;20:280-284.
6. VanCott AC, Cramer JA, Copeland LA, et al. Suiciderelated behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 2010;8:4.
7. Gibbons RD, Hur K, Brown CH, Mann JJ. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009;66:1354-1360.
8. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia 2009; 50:978-986.
9. Mula M, Hesdorffer DC. Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence. Drug Healthc Patient Saf 2011;3:15-20.
10. Bosco JL, Silliman RA, Thwin SS, et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol 2010; 63:64-74.
11. Psaty BM, Koepsell TD, Lin D, et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999;47:749-754.
12. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry 2006;163:41-47.
13. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158: 915-920.
14. Pugh MJ, Copeland LA, Zeber JE, et al. The impact of epilepsy on health status among younger and older adults. Epilepsia 2005;46:1820-1827.
15. Selim AJ, Berlowitz DR, Ren XS, et al. The comorbidity index. In: Davies M, ed. Measuring and Managing Health Care Quality. New York: Aspen Publishers; 2002: 91-94.
16. Selim A, Fincke G, Ren X, et al. Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage 2004;27:281-295.
17. Hope OA, Zeber JE, Kressin NR, et al. New-onset geriatric epilepsy care: race, setting of diagnosis, and choice of antiepileptic drug. Epilepsia 2009;50:1085-1093.
18. Juurlink DN, Herrmann N, Szalai JP, Kopp A, Redelmeier DA. Medical illness and the risk of suicide in the elderly. Arch Intern Med 2004;164:1179-1184.
19. Conwell Y, Brent D. Suicide and aging: I: patterns of psychiatric diagnosis. Int Psychogeriatr 1995;7:149-164.
20. Kaplan MS, Huguet N, McFarland BH, Newsom JT. Suicide among male veterans: a prospective populationbased study. J Epidemiol Community Health 2007;61: 619-624.
21. Hardin JW, Hilbe JM, eds. Generalized Estimating Equations, 1st ed. New York: Chapman & Hall/CRC; 2003.
22. Pugh MJ, Copeland LA, Zeber JE, et al. Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc 2012;60:2042-2047.
23. Hesdorffer DC, Berg AT, Kanner AM. An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr 2010;10:137-145.
24. Hawton K, Harriss L. How often does deliberate self-harm occur relative to each suicide? A study of variations by gender and age. Suicide Life Threat Behav 2008;38: 650-660.
25. Kim H, Smith E, Stano C, et al. Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res 2012;12:18.
26. Isacsson G, Holmgren P, Druid H, Bergman U. Psychotropics and suicide prevention. Implications from toxicological screening of 5281 suicides in Sweden 1992-1994. Br J Psychiatry 1999;174:259-265.
27. Centers for Disease Control and Prevention (CDC). The State of Aging and Health in America 2007. Whitehouse Station, NJ: The Merck Company Foundation; 2007.
28. American Foundation for Suicide Prevention. Risk factors for suicide [online]. Available at: http://www.afsp.org/index.cfm? page-id505147440-E24E- E376-BDF4BF8BA6444E76. Accessed January 22, 2013.
29. Kapur N, Cooper J, King-Hele S, et al. The repetition of suicidal behavior: a multicenter cohort study. J Clin Psychiatry 2006;67:1599-1609.
30. Scoliers G, Portzky G, van Heeringen K, Audenaert K. Sociodemographic and psychopathological risk factors for repetition of attempted suicide: a 5-year follow-up study. Arch Suicide Res 2009;13:201-213.